— Know what they know.
Not Investment Advice

DERM

Journey Medical Corporation
1W: -8.2% 1M: -21.6% 3M: -14.6% YTD: -11.0% 1Y: +15.3% 3Y: +370.2%
$6.63
-0.32 (-4.60%)
After Hours: $7.63 (+1.00, +15.16%)
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $152.8M · Alpha Radar Strong Sell · Power 34
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$152.8M
52W Range5.477-9.555
Volume663,968
Avg Volume122,728
Beta0.82
Dividend
Analyst Ratings
2 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOClaude Maraoui
Employees41
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-11-12
9237 East Via de Ventura Boulevard
Scottsdale, AZ 85258
US
480 434 6670
About Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Recent Insider Trades

NameTypeSharesPriceDate
Maraoui Claude M-Exempt 1,250,000 $0.07 2025-08-25
Maraoui Claude F-InKind 10,877 $7.47 2025-08-25
Maraoui Claude M-Exempt 1,250,000 $0.07 2025-08-25
ROSENWALD LINDSAY A A-Award 50,000 2025-08-05
Smith Justin Adam A-Award 20,000 2025-08-05

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms